Cargando…
SREKA-targeted liposomes for highly metastatic breast cancer therapy
Chemotherapy is still a leading therapeutic approach in various tumor types that is often accompanied by a poor prognosis because of metastases. PEGylated liposomes with CREKA targeting moiety are well-known therapeutic agents, especially in highly metastatic experimental models. CREKA specifically...
Autores principales: | Vári, Balázs, Dókus, Levente, Borbély, Adina, Gaál, Anikó, Vári-Mező, Diána, Ranđelović, Ivan, Sólyom-Tisza, Anna, Varga, Zoltán, Szoboszlai, Norbert, Mező, Gábor, Tóvári, József |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930758/ https://www.ncbi.nlm.nih.gov/pubmed/36752075 http://dx.doi.org/10.1080/10717544.2023.2174210 |
Ejemplares similares
-
Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer
por: Dókus, Levente E., et al.
Publicado: (2020) -
Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates
por: Gomena, Jacopo, et al.
Publicado: (2023) -
Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice
por: Ranđelović, Ivan, et al.
Publicado: (2019) -
In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery
por: Tripodi, Andrea Angelo Pierluigi, et al.
Publicado: (2019) -
Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker
por: Zambra, Marco, et al.
Publicado: (2023)